Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9609 posts found.

France cleans up regulation – and restricts pharma role

July 14, 2011 Research and Development, Sales and Marketing France, Mediator, Servier, pharmacovigilance, research and development news

France has unveiled sweeping changes to how it regulates prescription medicines following the scandal surrounding Servier’s Médiator. Health minister Xavier …
News

Paul Barrow joins CiToxLAB

July 14, 2011 Research and Development appointment, research and development

French CRO CiToxLAB has appointed Paul Barrow as director of scientific projects and client consulting. He joins the Evreux-based company, …
Appointment

Sanofi eyes phase III move for sarilumab in rheumatoid arthritis

July 13, 2011 Research and Development Regeneron, Sanofi, ankylosing spondylitis, research and development news, rheumatoid arthritis, sarilumab

Sanofi is poised to move sarilumab into phase III trials for rheumatoid arthritis after the monoclonal antibody showed positive results …
News
US Food and Drug Administration

Pharma regulators consult on drug development initiatives

July 13, 2011 Research and Development Companion Diagnostics, EMA, FDA, Pharmacogenomics, biomarkers, research and development news

Pharma regulators in the US and Europe have put out separate consultations on issues affecting how medicines are developed. The …
News
Amgen

Amgen collaborates on cancer antibody research

July 13, 2011 Research and Development Amgen, Cancer, TGF-beta monoclonal antibody, research and development news

Amgen has teamed up with German biotech Micromet to develop tumour-destroying antibodies in a two-year deal that could net Micromet …
News
clavis_pharma_nicholas_adams

Clavis Pharma appoints Nicholas Adams

July 13, 2011 Research and Development appointment, research and development

Norwegian cancer drug development company Clavis Pharma has appointed Nicholas Adams as chief business officer. He has more than 23 …
Appointment

Cellectis appoints Dr Andrew Scharenberg

July 12, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Paris-based genome engineering specialist Cellectis Therapeutics has appointed Dr Andrew Scharenberg as chief scientific officer. He is an attending physician …
Appointment

EMA plans adverse event reports for the public

July 12, 2011 Research and Development, Sales and Marketing EMA, adverse events, patient information

The EMA will start producing monthly adverse event reports for the public as part of its plans to open up …
News

Chiltern Announces New Legal Entity in Israel

July 11, 2011 Research and Development

 
News
Press release

Novartis’ Votubia reduces benign brain tumours in SEGA patients

July 11, 2011 Research and Development Novartis, SEGA, Votubia, everolimus

Novartis’ novel cancer drug Votubia has reduced the size of SEGA brain tumours in a late-stage trial. Votubia (or everolimus …
News

Kantar Health Names Werner Guminski CEO, Commercial Strategy

July 8, 2011 Business Services, Research and Development Kantar Health, commercial strategy

Kantar Health Names Werner Guminski CEO, Commercial StrategyNEW YORK, July 8, 2011—Kantar Health, a leading healthcare-focused global consultancy and marketing …
News
Press release

Lilly chief: German reforms jeopardise pharma innovation

July 8, 2011 Research and Development, Sales and Marketing Germany, John Lechleiter, lilly, medicines pricing

German healthcare spending cuts have gone too far and risk jeopardising pharmaceutical innovation in the country, according to Lilly’s chief …
News

Working through the ‘ZOUD’

July 7, 2011 Business Services, Research and Development, Sales and Marketing careers, management, recruitment

Most senior managers find their executive team difficult. ‘Dysfunctional’ is a favourite word. Testing dynamics, political agendas, big personalities, strong …
Feature

BMS licences potential first-in-class cancer biologic

July 7, 2011 Research and Development BMS, Cancer, biologics

Bristol-Myers Squibb has signed a $465 million deal for the rights to a potential first-in-class treatment for cancer. IPH2102 is …
News

Former Sanofi-Pasteur MSD president joins board at Genticel

July 6, 2011 Research and Development appointment, research and development

Genticel has named Dr Didier Hoch, former president of Sanofi-Pasteur MSD, to its supervisory board as conseil de surveillance.Dr Hoch …
Appointment
The Gateway to Local Adoption Series

Latest content

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026